Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
HK40015946A - Oxazole derivatives for use in the treatment of cancer - Google Patents
[go: Go Back, main page]

HK40015946A - Oxazole derivatives for use in the treatment of cancer - Google Patents

Oxazole derivatives for use in the treatment of cancer Download PDF

Info

Publication number
HK40015946A
HK40015946A HK62020005489.3A HK62020005489A HK40015946A HK 40015946 A HK40015946 A HK 40015946A HK 62020005489 A HK62020005489 A HK 62020005489A HK 40015946 A HK40015946 A HK 40015946A
Authority
HK
Hong Kong
Prior art keywords
cancer
treatment
oxazole derivatives
oxazole
derivatives
Prior art date
Application number
HK62020005489.3A
Other languages
Chinese (zh)
Inventor
Simon Osborne
Jonathan Large
Original Assignee
Lifearc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifearc filed Critical Lifearc
Publication of HK40015946A publication Critical patent/HK40015946A/en

Links

HK62020005489.3A 2016-12-29 2017-12-19 Oxazole derivatives for use in the treatment of cancer HK40015946A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201622362 2016-12-29

Publications (1)

Publication Number Publication Date
HK40015946A true HK40015946A (en) 2020-09-04

Family

ID=

Similar Documents

Publication Publication Date Title
ZA201803742B (en) Dihydroimidazopyrazinone derivatives useful in the treatment of cancer
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
EP3148532A4 (en) Pharmaceutical combination for the treatment of cancer
EP3307240A4 (en) Combination therapy for the treatment of cancer
ZA201807810B (en) Adenosine derivatives for use in the treatment of cancer
EP3245193A4 (en) Heterocyclic compounds for cancer imaging and treatment and methods for their use
EP3148526A4 (en) Use of eribulin in the treatment of cancer
EP3548028A4 (en) Treatment of cancer
IL266198A (en) Liposomal formulation for use in the treatment of cancer
EP3157336A4 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of ovarian cancer
IL248767B (en) Trimethoxyphenyl-benzimidazole compound for use in the treatment of cancer
IL280587B (en) Flurocytidine derivatives and its composition for the treatment of cancer
EP3113775A4 (en) Use of eribulin and mtor inhibitors as combination therapy for the treatment of cancer
EP3548007A4 (en) Methods for the treatment of cancer
EP3185910A4 (en) Methods and compositions for the treatment of cancer
EP3439651A4 (en) Improvements in cancer treatment
IL253933A0 (en) Pyrimidine derivatives for use in the treatment of cancer
IL269121A (en) Usl-311 for use in the treatment of cancer
HK40015947A (en) Oxazole derivatives for use in the treatment of cancer
HK40015946A (en) Oxazole derivatives for use in the treatment of cancer
EP3270898A4 (en) Methods for the treatment of bladder cancer
HK40018432A (en) Usl-311 for use in the treatment of cancer
HK40003303A (en) Adenosine derivatives for use in the treatment of cancer
HK40044464A (en) R-fadrozole for use in the treatment of aldostonerism
HK40008547A (en) Cobicistat for use in cancer treatments